Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF – Get Free Report) dropped 14.9% during trading on Monday . The company traded as low as $12.32 and last traded at $12.32. Approximately 375 shares changed hands during trading, an increase of 19% from the average daily volume of 315 shares. The stock had previously closed at $14.47.
Kyowa Kirin Stock Performance
The business’s 50-day simple moving average is $14.84 and its 200 day simple moving average is $17.48.
About Kyowa Kirin
Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.
Read More
- Five stocks we like better than Kyowa Kirin
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Finding Hidden Gems: Unconventional Penny Stock Investing
- What Do S&P 500 Stocks Tell Investors About the Market?
- Price Targets on NVIDIA Rise in Front of Earnings
- Stock Market Sectors: What Are They and How Many Are There?
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Receive News & Ratings for Kyowa Kirin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kyowa Kirin and related companies with MarketBeat.com's FREE daily email newsletter.
